Miromatrix Biological Mesh for Ventral Hernia Repair



Status:Withdrawn
Conditions:Gastrointestinal, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 80
Updated:10/5/2017
Start Date:June 2015
End Date:April 2016

Use our guide to learn which trials are right for you!

A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair

This study is being conducted to gather long-term data of the performance of the Miromatrix
Biological Mesh.

Miromatrix Medical Inc. has developed a new biologic mesh, called MIROMESH®. MIROMESH
received FDA 510(k) clearance with an indication for reinforcement of soft tissue on March
31, 2014 under K134033. Miromatrix Biologic Mesh is a non cross-linked, acellular surgical
mesh that is derived from the highly vascularized porcine liver. This study will serve to
provide clinicians with high-quality clinical data in order to provide them with a higher
degree of confidence when selecting MIROMESH for ventral hernia repair.

Inclusion Criteria:

- between 18 and 80 years old on the day of study enrollment

- ventral or incisional hernia greater than 9 cm2 for which the physician anticipates
ability to achieve midline fascia closure following a retro-rectus repair/component
separation

- hernia classified as CDC class 1 or 2 preoperatively

- able and willing to sign the consent form and comply with all study visits and
procedures

- commit to non-smoking for at least 4 weeks prior to procedure

Exclusion Criteria:

- sensitivity to porcine material

- scheduled for a concomitant procedure of a wound classified as other than clean

- immunocompromised or at risk of immunosuppression (i.e. be HIV positive, be
experiencing organ rejection, be a recent or anticipated chemotherapy recipient) as
determined by the Investigator

- BMI ≥40

- A1C level ≥10.0

- participating in another clinical study

- cirrhosis, and/or ascites

- diagnosed with a collagen vascular disorder

- American Society of Anesthesiology (ASA) Class 4 or 5

- allergic to tetracycline or kanacmycin

- life expectancy of less than 2 years at the time of enrollment

- any condition in the opinion of the Investigator that would preclude the use of the
study device, or preclude the subject from completing the follow-up requirements
We found this trial at
4
sites
Madison, Wisconsin 53792
(608) 263-2400
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Hershey, Pennsylvania 17033
2295
mi
from 91732
Hershey, PA
Click here to add this to my saved trials
Lexington, Kentucky
859) 257-9000
University of Kentucky The University of Kentucky is a public, land grant university dedicated to...
1881
mi
from 91732
Lexington, KY
Click here to add this to my saved trials
1700 S Tamiami Trail
Sarasota, Florida 34239
(941) 917-9000
Sarasota Memorial Hospital Sarasota Memorial Health Care System, an 806-bed regional medical center, is among...
2148
mi
from 91732
Sarasota, FL
Click here to add this to my saved trials